Circadin, Slenyto (melatonin) is a small molecule pharmaceutical. Melatonin was first approved as Circadin on 2007-06-29. It is used to treat jet lag syndrome and seasonal affective disorder in the USA. It has been approved in Europe to treat autistic disorder and sleep initiation and maintenance disorders. The pharmaceutical is active against melatonin receptor type 1A and melatonin receptor type 1B. In addition, it is known to target 5-hydroxytryptamine receptor 2B and Phenolic oxidative coupling protein.
|Trade Name||Circadin, Slenyto|
|Indication||autistic disorder, jet lag syndrome, seasonal affective disorder, sleep initiation and maintenance disorders|